BRANDYWINE MANAGERS, LLC - Q1 2021 holdings

$75.2 Million is the total value of BRANDYWINE MANAGERS, LLC's 46 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 16.0% .

 Value Shares↓ Weighting
TWLO BuyTWILIO INC - Acl a$3,333,000
+34.9%
9,782
+34.0%
4.43%
+30.4%
CRWD BuyDATADOG INCcl a$2,621,000
-12.4%
14,361
+1.7%
3.48%
-15.4%
GH BuyINTUITIVE SURGICAL INC$1,496,000
+63.5%
9,799
+38.0%
1.99%
+58.0%
TXG Buy10X GENOMICS INC - CLASS A$1,306,000
+114.4%
7,217
+67.8%
1.74%
+107.2%
MRNA BuyNATERA INC$1,245,000
+31.1%
9,510
+4.6%
1.66%
+26.7%
SDGR BuySCHRODINGER INC$1,176,000
+58.1%
15,420
+64.0%
1.56%
+52.8%
DOCU BuyDRAFTKINGS INC$1,116,000
-5.3%
5,511
+4.0%
1.48%
-8.5%
QTRX BuyQUANTERIX CORPORATION$1,092,000
+54.0%
18,678
+22.4%
1.45%
+48.8%
VEEV BuyWELLS FARGO CO NEW$1,013,000
+0.6%
3,876
+4.8%
1.35%
-2.8%
BEAM BuyBERKELEY LTS INC$886,000
-0.2%
11,067
+1.8%
1.18%
-3.5%
ISRG BuyIONIS PHARMACEUTICALS INC$861,000
+40.2%
1,165
+55.3%
1.14%
+35.5%
VRNS BuyVEEVA SYS INC$826,000
-1.0%
16,080
+215.3%
1.10%
-4.3%
BLI BuyC3 AI INC$809,000
+66.8%
16,103
+197.2%
1.08%
+61.2%
SEER BuySEER INC$769,000
+153.0%
15,366
+183.5%
1.02%
+144.5%
RLAY BuyROBLOX CORP$690,000
+101.2%
19,952
+141.8%
0.92%
+94.3%
ABCL BuyALNYLAM PHARMACEUTICALS INC$658,000
+82.8%
19,372
+116.8%
0.87%
+76.6%
ALNY BuyALNYLAM PHARMACEUTICALS INC.$651,000
+72.7%
4,608
+58.9%
0.86%
+67.0%
U BuyVARONIS SYS INC$550,000
-6.8%
5,486
+42.7%
0.73%
-9.9%
XLNX BuyXILINX, INC.$497,000
-2.5%
4,010
+11.4%
0.66%
-5.7%
NVDA BuyNVIDIA CORP$476,000
+13.9%
891
+11.4%
0.63%
+10.1%
NOW BuySERVICESOURCE INTL INC$447,000
+1.6%
893
+11.6%
0.59%
-1.8%
ANET BuyARISTA NETWORKS INC$416,000
+19.2%
1,379
+14.9%
0.55%
+15.2%
PANW BuyQUANTERIX CORP$398,000
+1.8%
1,235
+12.3%
0.53%
-1.7%
WFC NewXILINX INC$397,00010,160
+100.0%
0.53%
AI BuyC3.AI INCcl a$364,000
-11.4%
5,521
+86.4%
0.48%
-14.3%
TRHC NewTELADOC HEALTH INC$361,0007,832
+100.0%
0.48%
IONS NewKEURIG DR PEPPER INC$319,0007,085
+100.0%
0.42%
RBLX NewROBLOX CORP - CLASS Acl a$291,0004,491
+100.0%
0.39%
RGNX BuyREGENXBIO INC$235,000
-21.4%
6,900
+4.5%
0.31%
-24.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CROWDSTRIKE HLDGS INC37Q3 202394.6%
SERVICESOURCE INTL INC28Q3 20231.3%
WELLS FARGO CO NEW26Q3 20233.6%
OKTA INC25Q3 20237.4%
NVIDIA CORPORATION25Q3 20235.3%
IONIS PHARMACEUTICALS INC25Q3 20233.2%
TWILIO INC - A23Q3 20236.6%
QUANTERIX CORP21Q3 20232.0%
NATERA INC20Q3 20236.0%
ZUORA INC20Q3 20233.8%

View BRANDYWINE MANAGERS, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View BRANDYWINE MANAGERS, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (75239000.0 != 75243000.0)

Export BRANDYWINE MANAGERS, LLC's holdings